The worldwide incidence of cutaneous melanoma in populations of European descent has risen rapidly over the past 30 years, more so than that of any other malignancy 1 . The World Health Organization estimates 132,000 new cases of melanoma per year globally. Approximately 10% of malignant melanoma cases occur in multiplex families, with the CDKN2A locus in 9p21 accounting for susceptibility in 20-57% of all melanoma families 2 . However, remaining cases of familial melanoma do not carry mutations in CDKN2A and additional tumor suppressor genes at 9p21 and elsewhere have been proposed 3, 4 . Large numbers of nevi are the strongest known risk factor for melanoma 5 and in many familial cases susceptibility to melanoma is associated with an excess of nevi. Linkage to 9p21 has been found in two genome-wide analyses of nevus count 6, 7 , suggesting that shared genetic factors might be involved in melanoma susceptibility and nevogenesis. Understanding the genetic bases of nevus formation is therefore an important step in understanding melanoma etiology.
To search for loci involved in nevus count, we carried out a genome-wide association study (GWAS) in 1,524 healthy adult female twins from the TwinsUK registry using 297,108 SNPs with minor allele frequency (MAF) 4 1% on Illumina HumanHap 300k duo chips (see Online Methods). Total body nevus count was evaluated by trained research nurses and defined as the sum of all nevi at least 2 mm in diameter. Comparison of the observed and expected distributions (Supplementary Fig. 1 ) showed no evidence for inflation of the test statistics (inflation factor ¼ 1.006) and highlighted 46 SNPs having P values o 10 À4 against the expected 29. We selected 12 SNPs for follow-up that clustered in either the 9p21 or 22q13 chromosomal regions ( Fig. 1) . We replicated these SNP associations in an independent sample of 4,107 adolescent subjects of European ancestry from the Brisbane Twin Nevus Study (BTNS) for whom nevus count had been evaluated using a similar protocol (see Online Methods).
At the replication stage (Table 1) , the strongest association signal was observed for rs4636294 (combined P ¼ 3.4 Â 10 À15 ). This marker is located in the 5¢ UTR of the MTAP (methylthioadenosine phosphorylase) gene located at 9p21, next to CDKN2A (Fig. 2a) . The other replicated region on 22q13 (Fig. 2b) showed the highest combined association signal with rs2284063 (combined P ¼ 3.4 Â 10 À8 ). This SNP lies in the intron between the second and third exon of PLA2G6, belonging to the phospholipase A2 (PLA2) superfamily of genes 8 . The 9p21 and 22q13 loci accounted for 1.5% (UK) and 3.0% (Australia) and 1.9% (UK) and 0.7% (Australia) of nevus count variance, respectively.
The combined additive effect of rs4636294 and rs2284063 markedly increases the observed number of nevi. Indeed, subjects in the TwinsUK discovery sample homozygous for both variants (7%) had more than double the number of nevi (median number of nevi ¼ 30) compared to subjects homozygous for the protective alleles (median number of nevi ¼ 12.5). Subjects in the Australian BTNS sample are characterized by an overall larger number of nevi (median number of nevi ¼ 93 compared to 21 in the TwinsUK sample). Homozygous subjects for both variants in the Australian population (11%) also showed greater median number of nevi (116) than homozygous individuals for the protective alleles (79) ( Fig. 3 and Supplementary Table 1 ). Sun exposure varies greatly between the UK and Australian samples. The number of sunburns over a lifetime and the skin type (measured according to the Fitzpatrick classification) were not related to the number of nevi in either sample (see also Supplementary Table  2 for the distributions in the two countries). Therefore, adjusting for these two measures did not affect our results.
We explored whether these two genetic regions were also involved directly or indirectly in melanoma susceptibility by analyzing two melanoma case-control samples: the Queensland study of Melanoma, Environment and Genetic Associations (Q-MEGA), which included 1,734 cases and 1,811 controls of northern European origin, and the Leeds melanoma case-control study of North UK, which included 1,274 incident melanoma cases, 123 cases with a family history of melanoma, and 1,070 controls, plus 1,395 controls from the Wellcome Trust Case Control Consortium (WTCCC) 1958 birth cohort samples (see Online Methods for cohort details).
We derived joint odds ratios (OR) and confidence intervals under a fixed-effects model for each SNP, and associated P values from the standard normal distribution. As expected, we observed a small degree of heterogeneity for some of the SNPs shown by the lack of complete agreement for the highest association signals in the two samples. The highest combined ORs were 1.23 (95% CI ¼ 1.15-1.30) for rs10757257 at 9p21 and 1.23 (95% CI ¼ 1.15 -1.30) for rs132985 at 22q13 ( Table 2 and Supplementary Fig. 2 ). The top SNP-associated results in the nevus count analyses at each of these loci were as follows: Effect size (beta) and standard error (s.e.) are expressed in log (nevi). The meta-analytic P values are calculated using a weighted Z-score method. a BTNS Beta and s.e. are reported on the log scale to make them comparable to the TwinsUK results. P values have been evaluated using cube-root transformation, which better fits the BTNS data (Online Methods).
for 9p21 rs4636294, combined P ¼ 3.7 Â 10 À8 , OR ¼ 1.21 (95% CI ¼ 1.14-1.28) and for 22q13 rs2284063, combined P ¼ 1.
. Population attributable risk of the two loci reflected their different effect in the Australian and UK populations, ranging from 20.0% (Australia) to 9.0% (UK) for 9p21 and from 14.8 (Australia) to 29.3 (UK) for 22q13.
We used the Leeds sample to evaluate the combined risk for melanoma considering these two loci together (Supplementary Table 3 ). Individuals homozygous at the two loci showed nearly twice the risk for developing melanoma, in comparison of cases and controls in the Leeds cohort, as well as the controls from the WTCCC cohort (OR ¼ 1.94; 95% CI ¼ 1. 19-3.16) .
From the Leeds case-control study, 903 cases and 485 controls were assessed for their nevus phenotype through a standardized nevus count protocol, similar to that used in the TwinsUK sample. We used this subsample to explore whether the association between the identified loci and melanoma was direct or mediated by nevus count. Using these 485 controls, we verified that the effect of the nevus count loci was consistent with what was observed with the TwinsUK and BTNS samples. The results using this subsample were still consistent with those reported in Table 2 . Odd ratios for melanoma status were then compared with those obtained when the number of nevi was included in the logistic regression (Supplementary Table 4 ). When the association between melanoma and SNP was adjusted for nevus count, the OR for melanoma risk was reduced toward 1.0 and the P value became nonsignificant, consistent with melanoma risk being mediated via nevus count. It is notable that the OR was midway between the unadjusted OR and 1.0, which might be expected as nevus count would not be a perfect measure of risk Figure 3 Box plot of number of nevi for subjects in the TwinsUK (left) and BNTS (right) samples homozygous for both MTAP SNP rs4636294 and PLA2G6 SNP rs2284063 variants against the subjects homozygous for the protective alleles. Joint odds ratios and confidence intervals were evaluated under a fixed-effects model for each SNP. Associated P values were estimated from the standard normal distribution. The Leeds1 and Leeds2 datasets are described in the Online Methods.
(including error in its measurement). Indeed, nevus count is likely modified by other genetic influences as well as lifestyle factors. Supplementary Figure 3 shows the distribution of nevus count in the Leeds case-control sample stratified by genotype for the highest associations on 9p21 and 22q13. The location of the key SNPs in the 9p21 region is puzzling. They lie in the proximal promoter, 5¢ UTR and upstream from the coding region of the housekeeping gene MTAP, which encodes a key enzyme in the adenine and methionine salvage pathways. MTAP is often codeleted 9,10 with the adjacent melanoma susceptibility locus CDKN2A, which encodes p16INK4A and p14ARF (Fig. 4) . The loss of MTAP in some tumors has generally been attributed to its proximity to CDKN2A, but some studies suggest MTAP might function as an independent tumor suppressor 11, 12 . A novel fusion transcript has been reported that comprises the first four exons of MTAP plus exons 2 and 3 of the noncoding RNA ANRIL, which has its first exon in the CDKN2A promoter 13 . This points to complex regulation of several genes within this region (Fig. 4) . A possible hypothesis is that this scenario parallels that of common cancer susceptibility variants found earlier, where long-range regulatory effects on established oncogenes (MYC and FAM84B) have been postulated as a possible mechanism underlying multiple cancer associations mapping to a 1.2-Mb gene desert on 8q24 (ref. 14) .
The PLA2G6 gene on 22q13 belongs to the PLA2 superfamily of genes which encode esterases that cleave glycerophospholipids 8 . These enzymes are normally involved in the maintenance of membrane phospholipids, but have recently been shown to to be associated with lung cancer susceptibility 15 and to regulate cell growth 16 and apoptosis 17 , as well as cell proliferation in human tumors such as insulinoma, colon cancer, ovarian cancer and prostate cancer [18] [19] [20] .
We attempted to refine the location of chromosomes 9 and 22 association signals by imputing genotypes from the HapMap in the TwinsUK sample, and identified ten and four imputed SNPs on 9p21 and 22q13, respectively, that showed P values smaller than the strongest peak observed with the typed genotypes and might be helpful to identify some causal variants (Supplementary Table 5 ).
In the same issue of this journal, Bishop et al. 21 report a genome-wide association study for melanoma conducted by the GenoMEL consortium. In their initial GWAS cohort, melanoma cases from Europe and Australia were carefully selected to enrich for those with family history and earlier onset of disease, in order to increase power to detect genetic associations to susceptibility. They report three loci associated with melanoma (on chromosome 16q24, 11q14, and 9p21), with replication of these loci in two independent cohorts. The associated locus on chromosome 9p21, with a top association at rs7023329 (P ¼ 4.03 Â 10 À7 ), is also reported in our study. Bishop et al. also successfully attempted replication of our association on 22q13 at rs2284063 (P ¼ 2.40 Â 10 À9 ). The GenoMEL study involves melanoma cases and controls of diverse European ancestry, suggesting that the results presented in this paper generalize beyond English and Anglo-Celtic (Australian) ancestry.
Understanding how these genetic loci influence the development of nevi could provide important clues into the pathogenesis and treatment of melanoma, and may also prove of relevance for other cancers.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/. Figure 4 Ensemble ID: OTTHUMT00000051928.
Database accession numbers. Fusion transcript reported in
Note: Supplementary information is available on the Nature Genetics website. 
ONLINE METHODS
Subjects and phenotypes. TwinsUK. The St. Thomas' UK adult twin registry (TwinsUK) cohort is unselected for any disease and is representative of the general UK population. Nevus counts were collected at St. Thomas Hospital in London and the study was approved by the St. Thomas' Hospital Research Ethics Committee. Written informed consent was obtained from every participant in the study. Examination was performed by trained research nurses following a standardized and reproducible nevus count protocol 22 . The total body nevus count (excluding the genital area, breasts and posterior scalp) was defined as the sum of all nevi 42 mm in diameter Genotypic data were available for 1,524 subjects: 206 singletons, 832 dizygous (DZ) and 486 monozygous (MZ) twins. The median (first to third quartiles) age was 47 (37-54). The median (first to third) number of nevi was 21 .
BTNS and Q-MEGA. The Brisbane Twin Nevus Study (BTNS) is described in detail elsewhere 23 and comprised 4,107 adolescent twins, their siblings and parents (1,148 nuclear families) which have been recruited over 16 years into an ongoing study of genetic and environmental factors contributing to the development of nevi and other risk factors for skin cancer. The twins are recruited at age 12 years via schools around Brisbane, Australia, and followed up at age 14. All controls are screened to be unaffected by cutaneous malignant melanoma (CMM). The sample is overwhelmingly (495%) of northern European origin (mainly Anglo-Celtic).
Total body nevus counting has been performed on the adolescent twins and singleton siblings on two occasions by a trained nurse (at ages 12 and 14). There were 1,979 twins and singleton siblings where nevus counts and genotypes were available. Of the parents of the twins, 1,470 had self-reported nevus score and genotypes available.
The Australian melanoma cases (Q-MEGA) were a stratified sample of 1,734 subjects including all cases of melanoma diagnosed in the state of Queensland in the period 1982-1990, as described in detail elsewhere 24 . These individuals were originally studied between 1991 and 1994, but were recontacted and interviewed in 2002-2004. Controls for the present analysis come from the parents of the BTNS families. An additional 658 individuals were genotyped and contributed as controls for the melanoma case-control analysis.
All cases and controls gave informed consent to participation in this study, and the study protocol was approved by appropriate institutional review boards.
Leeds Case-Control Study. In this study, 1,274 population-based incident melanoma cases were recruited in a geographically defined area of Yorkshire and the Northern region of the UK. Overall, the study had a 63% response rate. Subjects were diagnosed between September 2000 and December 2006. Cases were identified by clinicians, pathology registers and via the Northern and Yorkshire Cancer Registry and Information Service cancer registry to ensure overall ascertainment. For the first three years of the study all individuals with invasive melanoma were invited to participate; subsequently, only individuals with Breslow thickness of at least 0.75 mm were invited as cases. The case series was supplemented by 123 melanoma cases with a family history of melanoma (at most two affected relatives) who were known to be negative for a CDKN2A mutation. CDKN2A is the most common gene mutated in the germline of multicase melanoma families; such mutations are found in an estimated 21% of three-case families (data not shown).
Controls were ascertained by contacting general practitioners to identify eligible individuals. These controls were frequency matched with cases for age and sex from general practitioners who had also had cases as part of their patient register. Overall there was a 55% response rate among controls (496 subjects). Additional controls were supplemented by a population-based group of 574 women who following informed consent agreed to participate in a study involving recording their history of sun exposure and sun bathing including sun-bed usage and for whom various measures of skin aging were recorded. DNA samples were also provided.
All participating individuals gave written informed consent and regional ethical committee approval was obtained.
The first 903 cases and all the controls were asked about UV exposure and other aspects of lifestyle and provided detailed information on the history of residency. A trained nurse interviewed all cases and controls and formed a standardized examination for skin nevi. Nevi were examined by body sector; nevi greater than 2 mm in diameter were counted.
Genotyping. The TwinsUK sample was genotyped using the Illumina HumanHap 300k duo chip, and population substructure was detected and removed as described previously 25 . The SNPs rs751173, rs4636294, rs2218220, rs1335510, rs1341866, rs10757257, rs7023329 and rs10811629 for MTAP and rs2284063, rs6001027, rs132985 and rs738322 for PLA2G6 were genotyped both in the Australian BTNS and Q-MEGA samples in multiplex assays designed using the Sequenom MassARRAY Assay Design software (version 3.0). SNPs were typed using Sequenom iPLEX chemistry on a MALDI-TOF Compact Mass Spectrometer (Sequenom). The 2.5 ml PCR reactions were performed in standard 384-well plates using 12.5 ng genomic DNA, 0.8 unit of Taq polymerase (HotStarTaq), 500 mmol of each dNTP, 1.625 mM of MgCl 2 , and 100 nmol of each PCRprimers (Bioneer). Standard PCR thermal cycling conditions and post-PCR extension reactions were carried out as described previously 26 . The iPLEX reaction products were desalted by diluting samples with 15 ml of water and adding 3 ml of resin. The products were spotted on a SpectroChip (Sequenom), and data were processed and analyzed by MassARRAY TYPER 3.4 software (Sequenom). None of SNPs showed Hardy-Weinberg disequilibrium, and there were no effects of ethnicity in both the control and case groups.
For the Leeds sample, genotyping data from the Illumina HumanHap300 v2 array were available for the 123 familial cases and for 148 cases and 167 controls (Leeds1 sample). The SNPs rs4636294, rs2218220 and rs7023329 for MTAP and rs2284063 and rs6001027 for PLA2G6 were genotyped in further 1,126 cases and 903 controls from the Leeds case-control study by Taqman with overall call rate greater than 97%. The Leeds1 sample plus the additional genotypes were part of the Leeds2 sample. None of SNPs showed deviation from HardyWeinberg equilibrium. Participants in the study were all of UK ancestry and principal component analysis (PCA) involving a subset of the samples included in this analysis found no evidence of population stratification. Both Leeds1 and Leeds2 case-control sample were supplemented with genotyping information from the Wellcome Trust Case Control Consortium (WTCCC) 1958 birth cohort control samples analyzed on the Illumina 550k array. Although data on 1,447 controls were provided by the WTCCC, these controls were reduced to 1,395 because of low call rate (call rate o 97%, n ¼ 51) and for apparent nonEuropean ancestry on the basis of PCA (n ¼ 1).
Statistical analyses. Power analysis for the TwinsUK discovery sample was performed using the Genetic Power Calculator. Assuming that the tested SNP is a good proxy for an untyped functional variant, we have 70% to 90% power of identifying a QTN responsible for 1% to 2% of the total genetic variance showing a P value required for a significant result after Bonferroni correction (P ¼ 0.05/297,108 ¼ 1.68 Â 10 À7 ). The GWA was performed in the TwinsUK sample using a rapid variance component association test implemented in MERLIN software version 1.1.2 (ref. 27 ) on the natural log-transformed nevus counts and including age in the model. The method estimates the additive effect of each SNP by fitting a simple regression model to the trait while using a variance component approach to model the correlation between different observed phenotypes within pairs. A quantile-quantile (Q-Q) plot was generated using R and visually inspected to detect strong inflation of the test statistics. The genomic inflation factor was calculated as the ratio of the median of the empirically observed distribution of the test statistic to the expected median to quantify the excess false-positive rate 28 and was found to be 1.006, close to its expected value of 1.0. Simulation analysis by gene dropping was carried out with MERLIN in the TwinsUK sample to assess the empirical P values for the most significant SNPs on chromosome 9 (rs10757257) and 22 (rs132985). By using 1 Â 10 À6 , we obtained empirical P values of 2 Â 10 À6 for rs10757257 and 2 Â 10 À6 for rs132985. Replication in the BTNS was carried out using MENDEL 29 , following cube-root transformation of the counts, and including age, age 2 , year studied, body surface area, estimated cumulative UV exposure, ancestry, hair and skin color as covariates.
For the Australian data, cube-root transformation was significantly better than log transformation based on the Box-Cox analysis, and it closely matched the results of a negative binomial generalized linear mixed model analyses of the BTNS data, which also improved significantly in terms of model-fit diagnostics.
Empirical P values were evaluated through straight regression of log(nevus count) versus allele count using MENDEL for gene dropping of the most significant SNPs on chromosomes 9 and 22. By using 1 Â 10 6 iterations, we obtained empirical P values of 1 Â 10 À6 for rs4636294 and 3.6 Â 10 À3 for rs2284063.
Combined P values from the BTNS and the TwinsUK studies were obtained using METAL. A z statistic is calculated for each marker using the P value and direction of the effect observed in each study. The combined P value is evaluated from the overall z statistic weighting each study proportionally to the square root of the number of subjects. The graphs in Figure 2 were generated by adapting a freely available R script 30 .
Given that some cases and all the controls have some relatives in the analysis, the case-control analysis in the Q-MEGA sample was carried out using MENDEL penetrance analysis option, and also the Sib-pair program. The latter was used to calculate simulation-based P values allowing for residual familial resemblance. We selected cases and controls where all four grandparents were reported to be of Northern European ancestry and we also performed quantitative-trait transmission disequilibrium test (TDT) analysis of nevus count, confirming that the observed associations were not due to population stratification.
For the Leeds analysis, case-control comparisons by SNP for melanoma were made by unconditional logistic regression. Analyses including nevus count involved age and sex adjusted nevus count. Tests of nevus count by SNP genotype were based on a test of linear trend of age and sex adjusted nevus count.
Meta-analysis for the melanoma case control association results was performed using the rmeta package of R. To refine the location of chromosomes 9 and 22 association signals and help the identification of some causal variants we imputed genotypes from the HapMap in the TwinsUK sample, as described previously 31 . An additional 665 and 309 SNPs in the 9p21 and 22q13 regions respectively were tested for association with nevus count.
URLs. Genetic Power Calculator, http://pngu.mgh.harvard.edu/~purcell/gpc/; R, http://www.r-project.org/; METAL, http://www.sph.umich.edu/csg/abecasis/ metal/; GenoMEL, http://www.genomel.org/.
